Shows / Oncology Data Advisor
Oncology Data Advisor
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
Episodes
Oncology Data AdvisorHow Clinical Intuition and Genomic AI Solved a Cancer Misdiagnosis Mystery
Read the article here: https://oncdata.com/how-clinical-intuition-and-genomic-ai-solved-a-cancer-misdiagnosis-mystery Artificial intelligence (AI) is creating…
Oncology Data AdvisorThe Documentation Burden: When Clicking Boxes Competes With Patient Care
Read the full article here! https://oncdata.com/oncology-unfiltered-the-documentation-burden Electronic health records (EHRs) and digital workflows were…
Oncology Data AdvisorReimagining Oncology Education With Human-Guided AI
Read the full article here: https://oncdata.com/reimagining-oncology-education-with-ai New clinical trials, guideline updates, therapeutic approaches, and…
Oncology Data AdvisorPersonalizing Surgical Risk Assessment in Lung Cancer With AI
Read the full article here: https://oncdata.com/personalizing-surgical-risk-assessment-in-lung-cancer For many patients with lung cancer, surgery offers the…
Oncology Data AdvisorClinical Trial Enrollment Barriers: Awareness Isn’t the Same as Access
Check out the full article at: https://oncdata.com/oncology-unfiltered-clinical-trial-enrollment-barriers While clinical trials represent the cutting edge of…
Oncology Data AdvisorBuilding Trust in Real-World Evidence With AI and High-Quality Data
Read the full article at: https://oncdata.com/real-world-evidence-ai-in-oncology Artificial intelligence (AI) is rapidly transforming oncology research, but…
Oncology Data AdvisorOne Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
Read the full article at: https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging As healthcare increasingly shifts from reactive treatment to…
Oncology Data AdvisorAI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) continues to…
Oncology Data AdvisorAdvancing Extrapulmonary NEC: DLL3 & Beyond
Are you treating extrapulmonary neuroendocrine carcinomas based on where they start—or what they actually are? In this faculty follow-up to their i3 Health…
- Oncology Data Advisor
Prostate Cancer Breakthroughs: TALAPRO-3, PROTEUS, & Earlier Therapy
What if hitting prostate cancer earlier and harder is the key to delaying disease progression and sparing patients from invasive salvage therapies? In this…
- Oncology Data Advisor
Advances in CIDP: Consensus Definitions, Emerging Pipeline & Individualized Care
Chronic inflammatory demyelinating polyneuropathy (CIDP) presents significant challenges in both diagnosis and long-term disease management. As consensus…
Oncology Data AdvisorInformation Overload and the Portal Patient: The Era of Instant Test Results
Read the full article here: https://oncdata.com/information-overload-and-the-portal-patient The way that patients receive medical information has changed…
Oncology Data AdvisorOne Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
Read the full article here! https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging As healthcare increasingly shifts from reactive treatment…
Oncology Data AdvisorPrecision Decisions in NDMM: Live Virtual Rounds Preview
Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies…
Oncology Data AdvisorMultidisciplinary Realities: Tumor Board vs Tuesday Afternoon
View the full article at: https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon Tumor boards play a pivotal role in oncology care. For…
- Oncology Data Advisor
The Real World vs The Trial Patient: Bridging the Gap
Check out the full article at: https://oncdata.com/oncology-unfiltered-the-real-world-vs-the-trial-patient Every oncologist knows the moment well: you're…
- Oncology Data Advisor
AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) continues to…
Oncology Data AdvisorSolving the PFIC Mystery: Genetic Testing and Diagnosis in Adults
Think PFIC is only a pediatric disease? Think again. Progressive Familial Intrahepatic Cholestasis (PFIC) was long considered a condition exclusive to…
- Oncology Data Advisor
HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI
Read the full article at: https://oncdata.com/exploring-ai-helioliver Patients diagnosed with early-stage liver cancer have a significantly higher survival…
- Oncology Data Advisor
New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian
The treatment of esophagogastric cancer is undergoing a profound transformation. In this episode, Yelena Janjigian, MD (MSKCC), discusses how perioperative…
Oncology Data AdvisorHER2-Mutant NSCLC Update: Expanded Approval of Zongertinib
Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape!…
- Oncology Data Advisor
Choosing Not to Treat: How Do You Know When the Best Treatment Is No Treatment?
Choosing Not to Treat: How Do You Know When the Best Treatment Is No Treatment? by i3 Health
- Oncology Data Advisor
Additional Advances in Systemic Mastocytosis Research and Clinical Trials With Mariana Castells, MD, PhD
Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care…
- Oncology Data Advisor
The Future of Hemophilia: New Data, New Guidance, New Outcomes with Robert F. Sidonio, Jr., MD, MSc
Hemophilia care is evolving faster than ever. Dr. Robert Sidonio, Jr., a leading expert from Children’s Healthcare of Atlanta, joins us to discuss the latest…
Oncology Data AdvisoriNav: How AI-Driven Navigation Is Accelerating Pancreatic Cancer Care
Read the full article at: https://oncdata.com/inav-daniel-king Pancreatic cancer remains one of oncology’s most challenging diseases—fast-moving, hard to…
- Oncology Data Advisor
Closing the Gaps in NET Diagnosis and Treatment: A Conversation With Aman Chauhan, MD
Neuroendocrine tumor (NET) care is changing fast—and the pace of innovation is only accelerating. In this episode, Aman Chauhan, MD, Associate Professor of…
Oncology Data AdvisorMolecular Testing Chaos: Are We Over Testing, Under Testing, or Testing the Wrong Things at the Wrong Time?
Read the full article on Oncology Data Advisor: https://oncdata.com/oncology-unfiltered-molecular-testing In the rapidly evolving landscape of modern oncology…
- Oncology Data Advisor
If a Patient Can’t Afford to Fill the Prescription, Is It Really a Treatment Option?
Read the full article on Oncology Data Advisor: https://oncdata.com/oncology-unfiltered-financial-toxicity In this episode of Oncology Unfiltered, Melissa…
- Oncology Data Advisor
Living with Psoriatic Arthritis: A Patient’s Perspective on Biologics, Weight Loss & Early Diagnosis
Psoriatic arthritis management is evolving fast, but bridging the gap between clinical evidence and patient experience remains the ultimate challenge. When…
- Oncology Data Advisor
Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 2
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians…
- Oncology Data Advisor
Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 1
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians…
Oncology Data AdvisorNavigating HER2-Mutant NSCLC Pathology and Management: A Webinar Preview With Helena A. Yu, MD, and Maria Arcila, MD
Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on…
Oncology Data AdvisorDiscovering Systemic Mastocytosis in Practice: A Webinar Preview With Lauren M. Madigan, MD
Join Lauren M. Madigan, MD, Associate Professor of Dermatology at the University of Utah, for a sneak peek at our upcoming live webinar, Beyond the Skin…
- Oncology Data Advisor
Improving Early and Equitable Lung Cancer Detection With Sybil: Mary Pasquinelli, DNP, FNP-BC, CTTS, and Waqas Haque
Click here to view the full article on Oncology Data Advisor: https://oncdata.com/mary-pasquinelli-sybil-ai In this episode of Exploring AI in Oncology, Dr…
- Oncology Data Advisor
Additional Advances in Systemic Mastocytosis With Mariana Castells, MD, PhD + Module 2
Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care…
- Oncology Data Advisor
Additional Advances in Systemic Mastocytosis Research and Clinical Trials With Mariana Castells, MD, PhD + Module 1
Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care…
- Oncology Data Advisor
Charting New Paths in Oncology Informatics With Travis Osterman, DO, and Waqas Haque, MD, MPH
Read the full article at: https://oncdata.com/travis-osterman-ai-informatics In this episode of Exploring AI in Oncology, Dr. Waqas Haque speaks with Dr…
- Oncology Data Advisor
Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management
Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest…
- Oncology Data Advisor
Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets
Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive tumors that present unique diagnostic and treatment challenges. In this accredited…
- Oncology Data Advisor
From Abstracts to Action: How ASCOmind Streamlines Oncology Insights With Xiaoyan Wang, PhD; William Oh, MD; and Waqas Haque, MD, MPH
Click here to view the full article on Oncology Data Advisor: https://oncdata.com-ai-ascomind ASCOmind is a novel artificial intelligence (AI) framework…
Oncology Data AdvisorEsophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD…
- Oncology Data Advisor
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD…
- Oncology Data Advisor
Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC
Genetic testing and counseling are crucial components of precision medicine in cancer care, enabling clinicians to deliver the right care, to the right…
- Oncology Data Advisor
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2
i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives…
- Oncology Data Advisor
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 1
i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives…
- Oncology Data Advisor
Unmasking Hereditary ATTR-CM: A Webinar Preview With Mathew Maurer, MD
oin i3 Health for a special live webinar, Increasing Detection and Improving Outcomes in Hereditary Transthyretin Amyloid Cardiomyopathy, being held on…
- Oncology Data Advisor
Multicancer Early Detection: A Fellow’s Perspective With Waqas Haque, MD, MPH
Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Waqas Haque, a…
- Oncology Data Advisor
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD
As research in dedifferentiated liposarcoma (DDLPS) continues to advance, the importance of multidisciplinary collaboration and access to innovative therapies…
- Oncology Data Advisor
Exploring the Evolution of Neuroendocrine Tumor Diagnostics and Therapeutics: A Webinar Preview With Aman Chauhan, MD
Join i3 Health for a special live webinar, Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care, being held on Thursday, July 17th…
Oncology Data AdvisorA Return on Humanity: How the American Cancer Society Uses AI to Improve Patient Care
A Return on Humanity: How the American Cancer Society Uses AI to Improve Patient Care by i3 Health
- Oncology Data Advisor
Challenges and Innovations in Biliary Tract Cancer: A Multidisciplinary Task Force Perspective
Biliary tract cancer (BTC) presents a complex puzzle for the interprofessional healthcare team. With its diverse subtypes and unique molecular features…
- Oncology Data Advisor
Building Effective AI Foundation Models at Standard Model Biomedicine With Kevin Brown and Waqas Haque, MD, MPH
Read the full article for this interview here: https://oncdata.com/standard-model-biomedicine Artificial intelligence (AI) is rapidly transforming the…
- Oncology Data Advisor
Reimagining Oncology Nursing Through AI Innovations: Waqas Haque, Kathleen McGrow, Sangeeta Agarawal, Marc Perkins-Carrillo
Read the full article here: https://oncdata.com/reimagining-oncology-nursing-through-ai In this episode of the Exploring AI in Oncology series, Dr. Waqas…
- Oncology Data Advisor
Harnessing AI for Early Lung Cancer Detection: Qure.ai’s Innovations and Impact
In this episode of the Exploring AI in Oncology podcast, Waqas Haque, MD, MPH, a Hematology/Oncology Fellow at the University of Chicago, speaks with Samir…
Oncology Data AdvisorAdditional Advances in Relapsed/Refractory Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
The fight against relapsed/refractory multiple myeloma is evolving rapidly, with groundbreaking research and clinical trials paving the way for innovative…
- Oncology Data Advisor
Additional Advances in Stem Cell Mobilization Research and Clinical Trials in Multiple Myeloma With Hamza Hashmi, MD
March marks Multiple Myeloma Awareness Month, a crucial time to highlight advances in the treatment of this complex blood cancer. Multiple myeloma is the…
- Oncology Data Advisor
Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC
As we recognize Kidney Cancer Awareness Month this March, advancements in renal cell carcinoma (RCC) treatment continue to evolve. Recently, Nazy Zomorodian…
- Oncology Data Advisor
From Glass Slides to AI: How Digital Pathology and MRD Testing Are Transforming Cancer Care With Osama Khan, MD, and Waqas Haque, MD, MPH
In this episode of the Exploring Artificial Intelligence (AI) in Oncology series, Waqas Haque, MD, MPH, Hematology/Oncology Fellow at the University of…
Oncology Data AdvisorHow AI Is Revolutionizing Precision Oncology With Ian Maurer and Jasmin Hundal, MD, MS, MPH
The role of artificial intelligence (AI) and machine learning (ML) in precision oncology has expanded rapidly, offering promising tools for clinicians and…
- Oncology Data Advisor
Mendel AI: Enhancing Clinical Data Processing for Empowered Clinical Decision Making With Kristin Maloney, MS, BSN, RN, OCN®, and Waqas Haque, MD, MPH
Artificial Intelligence (AI) is revolutionizing healthcare, and oncology is no exception. In this episode of the Exploring AI in Oncology series, Kristin…